NeuroMetrix Introduces Quell 2.0 Wearable AI Pain Relief Technology at CES 2019

NeuroMetrix pain relief
Image: Quell Relief

NeuroMetrix, an innovation-driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes, launched a revolutionary wearable device called Quell 2.0 that uses artificial intelligence to relieve pain at CES 2019.

Related Study: Electrostimulation Therapy Benefits Majority of Americans Seeking Drug-Free Pain Relief from Injuries

Transcutaneous electrical nerve stimulation (TENS) therapy is for the treatment of chronic pain. The therapy has been around for decades, but NeuroMetrix is taking TENS therapy to a new level with its new device.

In 2016, approximately 20% of U.S. adults had chronic pain and 8% had high-impact chronic pain—meaning pain that limited at least one major life activity. The economic costs of chronic pain management is estimated to be $635 billion per year.

The new Quell 2.0 is smaller (about 50% smaller) than the company’s original product, but sports a larger battery that can provide more juice and more therapy sessions per charge. The device is also more powerful than any other TENS device on the market, and in fact, is about 10 times more powerful than the regular TENS units that are sold over-the-counter.

Quell 2.0 on display at CES (Image: Quell via Twitter)

Here at CES, we’re really talking about two additional innovations that we’re unveiling and it will become commercial quite soon,” NeuroMetrix CEO Shai Gozani told Michael Ostrovsky of MedGadget. “The first is AI enhancements to the Quell device. What that means is we’ve applied machine learning to a very large database that we have. We believe we have the largest chronic pain database in the world. Seventy thousand people using Quell are contributing data via the device which records sleep and activity, as well as their clinical information, pain level all via the app. The second thing we’re introducing here is the therapy coach. This is important because chronic pain develops over years or decades, so it can’t be corrected overnight. So, what we’ve done is we’ve gamified the first 30-60 days which is the period over which you’ll experience pain relief.”

Related CES 2019: Oska Wellness Will Debut Next-Gen Wearable Pain-Relief Device

Redesigned Quell App. Based on user feedback, NeuroMetrix has updated the app with an all-new easy-to-use interface and intuitive design. The app enables users to calibrate Quell to their precise needs, start and stop therapy, choose a variety of customization and automation features, and track therapy, sleep, activity and pain.

Previous articleJohnson & Johnson Collaborates with Apple to Use its App with Apple Watch in AFib Study
Next articleSyncThink Partners with Magic Leap to Use AR for Brain Health Assessment
Sam Draper
Sam Draper () is Online Editor at WT | Wearable Technologies specialized in the field of sports and fitness but also passionated about any new lifestyle gadget on the market. Sam can be contacted at press(at)